Alternative protein is no longer limited to ESG investment theses. Breakthroughs in the space have brought it to the attention of a broader investor base, and the pandemic has underlined its importance as part of any forward-looking investment thesis. Andrew Ive, General Partner at Big Idea Ventures, is joined by Dr. Dalal Alghawas, Program Director at Big Idea Ventures Singapore and Nieves MartÃnez Marshall, Founder & CEO of Novel Farms, to discuss investment trends they see in the space, remaining gaps in the market and innovations we can anticipate in the future.